This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Apr. 30, 2013


 



Variations on a gene, and tools to find them
The New York Times
Cancers were once named strictly for the tissue where they originated in the breast, prostate or other part of the body. Now, in the age of genetically informed medicine, cancers may also come with a more specific lexicon: the names of mutated genes deep within tumors that cause cells to become cancerous.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


Medicare panel to mull genetic cancer tests
MedPage Today
Genetic tests to help oncologists determine the previously unknown origin of metastatic tumors work moderately well, members of a Medicare coverage advisory committee were told. However, analytic and clinical evidence is limited on another category of genetic tests: those that search for DNA from high-risk, cancer-causing human papillomavirus to detect cervical cancer earlier.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Minorities wait longer for breast cancer surgery
Reuters
Among young women diagnosed with breast cancer, black and Hispanic patients were more likely to wait weeks for treatment, in a new study from California. Researchers found treatment delays were also more common among poor women and those without private insurance — and that a woman's chance of surviving at least five years after cancer surgery was lower when it was put off.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
See related story: Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity (JAMA Surgery)


PRODUCT SHOWCASE
  Why are other doctors making more money than you!

What are you doing wrong or right? The ASC Billing Specialists at MediGain are seeing it more and more as they work to increase revenue in Ambulatory Surgery Centers across the country; you have to “Get Back to Basics!” With more and more changes coming in healthcare it is even more important to have your team solid on the basics.
 


Publication bias, not conflicts, may be bigger concern in cancer trial reports
Modern Healthcare
A new study of conflicts of interest in leading cancer journals' reports about phase 3 clinical trials showed financial connections between the study authors or editorialists and the companies that either sponsored the trials or had a stake in their outcome had little impact on interpretation of the results.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Skin cancer Tx no help for sick older patients
MedPage Today
Surgical treatment of nonmelanoma skin cancer in elderly patients with other underlying health conditions may do more harm than good, researchers found. In a cohort of nonmelanoma skin cancer patients, those with limited life expectancy experienced more complications with therapy (20 percent) than those who did not have limited life expectancy (15 percent), according to Dr. Eleni Linos of the University of California San Francisco, and colleagues.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword MELANOMA.


  FEATURED COMPANIES
Oncology OnTrack Supports Nurse Navigation
Oncology OnTrack is used to navigate patients with any cancer type from screening to diagnosis, treatment and survivorship, interfaces with other programs and supports accreditations.
Advertise here!

To find out how to feature your company in The CoC Brief and other advertising opportunities, contact James DeBois at 469-420-2618.
MORE


National Cancer Survivors Day free poster
Commission on Cancer
The CoC encourages your CoC-accredited program to organize an event in honor of National Cancer Survivors Day. Sponsored by Coping, this day is always the first Sunday in June and was established to bring cancer survivors together showing that there is life after receiving a diagnosis of cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Breast cancer drug enhanced for aggressive types
Bioscience Technology
Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease. Now, a University of Rochester Medical Center team has shown how to exploit tamoxifen's secondary activities so that it might work on more aggressive breast cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Learn how surgeons can get involved in oncology clinical trials
American College of Surgeons Clinical Research Program
If you plan to attend the American Society of Breast Surgeons meeting May 1-5 in Chicago be sure to attend the surgical investigators meeting from 12:30-1:30 p.m. May 4 in the Columbia Room at the Sheraton Chicago Hotel and Towers. Sponsored by the American College of Surgeons Clinical Research Program and the Alliance for Clinical Trials in Oncology, this lunch meeting will provide an informal venue for surgical investigators to network with one another about how to navigate the often complex world of oncology clinical trials. Speakers at the session will present information on Alliance breast cancer trials and how individual surgeons can get more involved in research opportunities and clinical trials offered by the ACS CRP and the Alliance. For more information, please email clinicalresearchprogram@facs.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Sequester could doom funding for promising cancer research
Healthcare Finance News
An advanced stage cancer diagnosis used to be almost a death sentence, but that wouldn't have to be the case if we were wise in sustaining cancer research funding. If we chose to fund more promising cancer research proposals, perhaps no child would have to die or grow up without a parent; no young couple would see their life dreams shattered by a life-threatening diagnosis, and no one would spend years wracked with uncontrollable cancer pain or nausea from chemotherapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Registration now open for Survey Savvy 2013
Commission on Cancer
Learn new methods for successful implementation of the CoC Standards at Survey Savvy: Enhance Quality – Commit to Patient Centered Care, June 27-28 in Chicago. Developed to provide information and tools for meeting the standard, the program highlights a variety of successful strategies to meet the patient navigation and survivorship care plan and quality standards. Panel presenters will facilitate a series of breakout sessions where participants will be engaged in developing an action plan to address challenging issues in their cancer program. Additional information on the program will be available soon.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Prostate cancer rate higher than expected in WTC workers
Urology Times
Incidence rates for prostate and other cancers are statistically higher than expected among World Trade Center rescue and recovery workers, according to a recent study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Survey Savvy preconference RQRS workshop
Commission on Cancer
Commission on Cancer accredited programs have access to a number of data tools. Make sure that you are taking full advantage of the information available from the Rapid Quality Reporting System by attending this important half-day preconference in Chicago on June 26. Learn how to navigate the system, how to use the system for quality improvement, and how current users have successfully implemented and use RQRS within their cancer programs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 




The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Andrew Plock, Content Editor, 469.420.2609  
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

May 1, 2013
April 24, 2013
April 17, 2013
April 10, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063